Quintet Private Bank (Europe)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Quintet Private Bank (Europe)'s GILD Position: Q2 2026 in Review
Quintet Private Bank (Europe) increased its Gilead Sciences (GILD) stake by 7.2% in Q2 2026, buying an estimated $16.9K and bringing the position to 1,896 shares worth $240K. The position accounts for 0.01% of the portfolio, ranked #103.
Quintet Private Bank (Europe) first reported a position in GILD in Q2 2022 and has held it in 15 quarters since. The position peaked at $791K in Q1 2023. 1,050 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Quintet Private Bank (Europe) held 1,896 shares of Gilead Sciences worth $240K as of Q2 2026.
- Quintet Private Bank (Europe) bought 128 Gilead Sciences shares in Q2 2026, an estimated $16.9K.
- Gilead Sciences made up 0.01% of Quintet Private Bank (Europe)'s portfolio in Q2 2026, its #103 holding.
- Quintet Private Bank (Europe) first reported a position in Gilead Sciences in Q2 2022 and has held it in 15 quarters since.
- Quintet Private Bank (Europe)'s Gilead Sciences position peaked at $791K in Q1 2023.
- 1,050 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Quintet Private Bank (Europe)'s 13F filing for Q2 2026, filed 13 Jul 2026.